Alveolus Bio Secures Investment to Advance Lung Disease Therapies

A company called Alveolus Bio, which makes new medicines for lung problems, got a big investment from a company called Shilpa Medicare.

Shilpa Medicare will also help Alveolus Bio make these medicines.

This will help Alveolus Bio move its medicines into the next stages of testing, including Phase 2 and trials with people.

Alveolus Bio is working on a special way to get medicines into the lungs to treat diseases like COPD, BPD, and Pulmonary Fibrosis.

The money from Shilpa Medicare will help them make these medicines faster and get them to people who need them.